Skip to main content

Table 2 Classification base on the platinum response and the AUC value using the clearance of HE4 and CA125

From: Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer

 

Platinum sensitive

Platinum resistant

Sensitivity

Specificity

PPV

NPV

Accuracy

P-value

AUC

 

HE4 clearance

HE4 non-clearance

       

1 cycle

55/73 (75.3%)

10/16 (62.5%)

62.5%

75.3%

35.7%

90.2%

73.0%

0.018

0.689

3 cycle

59/73 (80.8%)

12/16 (75.0%)

75.0%

80.8%

54.5%

93.7%

79.8%

0.000

0.779

6 cycle

61/73 (83.6%)

10/16 (62.5%)

62.5%

83.6%

45.5%

91.0%

79.8%

0.004

0.730

 

CA125 clearance

CA125 non-clearance

       

1 cycle

52/73 (71.2%)

12/16 (75.0%)

75.0%

71.2%

36.4%

92.9%

71.9%

0.004

0.731

3 cycle

69/73 (94.5%)

6/16 (37.5%)

37.5%

94.5%

60.0%

87.3%

84.3%

0.046

0.660

6 cycle

71/73 (97.3%)

6/16 (43.8%)

43.8%

97.3%

77.8%

88.8%

87.6%

0.011

0.705

 

HE4 or CA125 clearance

Both HE4 and CA125 non-clearance

      

3 cycle of HE4 or 1 cycle of CA125

42/73 (57.5%)

16/16 (100%)

100.0%

57.5%

34.0%

100.0%

65.2%

0.000

0.788

 

Both HE4 and CA125 clearance

HE4 or CA125 non-clearance

       

3 cycle of HE4 and 1 cycle of CA125

69/73 (94.5%)

8/16 (50.0%)

50.0%

94.5%

66.7%

89.6%

86.5%

0.005

0.723